Patients with both active and inactive BD had Increased levels of sCD40L in their plasma, that induced ROS and NET production in neutrophils, and increased expression of Mac-1 that together could contribute to binding to vasculature [39]. This evidence concerns the gene CD40LG and Behcet disease.